Developing individually-tailored immunotherapies is one of the highest aspirations of cancer researchers. Now, new work suggests deep-learning technology can accurately predict which cancer-related protein fragments—neoepitopes—are most likely to trigger an immune system response to a specific tumor.This tool could help in development of personalized immunotherapies and vaccines, according to the team of Johns Hopkins engineers […]
